683 Capital Management’s Biostage, Inc. Common Stock BSTG Stock Holding History

683 Capital Management’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-200,700	Closed	-$652K	–	98
2015 Q1	$652K	Buy	200,700 +84,400	+73%	+$288K	0.25%	55
2014 Q4	$370K	Sell	116,300 -48,500	-29%	-$240K	0.16%	51
2014 Q3	$1.33M	Buy	164,800 +20,811	+14%	+$170K	0.46%	39
2014 Q2	$1.5M	Buy	143,989 +43,837	+44%	+$373K	0.57%	35
2014 Q1	$908K	Buy	+100,152	New	+$594K	0.35%	43

Other funds holding BSTG

State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

WIC

Woodmont Investment Counsel Nashville, Tennessee $1.62B AUM 18.92% 1-Year Est. Return

683 Capital Management's BSTG Position: Q2 2015 in Review

683 Capital Management sold out of Biostage, Inc. Common Stock (BSTG) in Q2 2015, closing a stake of 200,700 shares — an estimated $652K sold.

683 Capital Management first reported a position in BSTG in Q1 2014 and held it in 5 quarters. The position peaked at $1.5M in Q2 2014. 32 funds tracked by Wall St. Rank hold BSTG as of Q2 2015.

683 Capital Management reported no remaining Biostage, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
683 Capital Management sold 200,700 Biostage, Inc. Common Stock shares in Q2 2015, an estimated $652K.
683 Capital Management first reported a position in Biostage, Inc. Common Stock in Q1 2014 and held it in 5 quarters.
683 Capital Management's Biostage, Inc. Common Stock position peaked at $1.5M in Q2 2014.
32 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q2 2015.

Based on 683 Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.